Virus Entry Inhibitors
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Informatics".
Deadline for manuscript submissions: 30 June 2024 | Viewed by 1225
Special Issue Editor
Interests: rational design of antiviral drugs, e.g., virus entry/fusion inhibitors, protease inhibitors, etc.; computer-assisted drug design; structure-based drug design; ligand-based drug design; virtual screening; QSAR; 3D-QSAR; pharmacophore mapping
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are pleased to inform you of the launch of a Special Issue on “Virus Entry Inhibitors” in IJMS. Virus entry into host cells is the first step of all enveloped and non-enveloped viruses. Virus entry inhibitors are a class of antiviral drugs that prevent the entry or fusion of a virus into a host cell. These inhibitors target specific mechanisms or proteins involved in the virus entry process, thereby blocking the virus from infecting the host cell.
Considerable progress has been made in this area of research, especially since the FDA approved the first HIV-1 fusion inhibitor, enfuvirtide (brand name Fuzeon), and CCR5 antagonist maraviroc (brand name Selzentry).
With this Special Issue, we will aim to provide an overview of the latest progress in the development of entry inhibitors that include small molecules, peptidomimetics, and that are peptide-based or antibody-based (such as broadly neutralizing antibody (bNAb), etc. We also want to encourage the submission of novel findings on virus entry mechanisms, preclinical and clinical assessments of virus entry inhibitors, and the future trends in developing these inhibitors.
We encourage the submission of original research articles, brief communications, reviews, and commentaries. We look forward to receiving your contributions.
Dr. Asim Debnath
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- viral entry
- entry inhibitors
- small molecules
- peptidomimetics
- peptide-based
- broadly neutralizing antibody (bNAb)
